Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0000921895-25-001730

Options or other derivatives

  • Director acquired 6,682 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
BVF PARTNERS L P/IL Director 2025-06-05 Grant or award · Option to Buy +6,682 6,682 I
Loading xslF345X05/form407422010_06092025.xml…